Literature DB >> 6146738

The mode of action of analgesic drugs in adjuvant arthritic rats as an experimental model of chronic inflammatory pain: possible central analgesic action of acidic nonsteroidal antiinflammatory drugs.

S Okuyama, H Aihara.   

Abstract

The analgesic activities of intracerebroventricular (icv) administrations of some analgesic drugs, morphine, indomethacin, diclofenac, aminopyrine and acetaminophen, were studied in comparison with those of systemic administrations in normal rats and adjuvant arthritic rats. A method for the measurement of analgesic potency in normal rats and adjuvant arthritic rats were developed using the vocalization response as an indicator of pain resulting from electrical stimulation. The systemic and/or icv administered indomethacin and diclofenac produced much more potent analgesic action in adjuvant arthritic rats than in normal rats. Morphine, aminopyrine and acetaminophen given by the two routes showed roughly the same analgesic effect in both types of rats. Simultaneous systemic and icv administrations of indomethacin and/or diclofenac showed an additive effect in normal rats, but showed a synergistic effect rather than a simple additive effect in adjuvant arthritic rats. Those of morphine, aminopyrine and acetaminophen showed only additive effects in both types, except for that of aminopyrine in normal rats. Moreover, the brain and serum levels of non-metabolized indomethacin and aminopyrine were measured after the normal and adjuvant arthritic rats were systemically given these drugs. In adjuvant arthritic rats, the icv effective dose of indomethacin was the same as the brain level of non-metabolized indomethacin after the systemic administration. The effective dose of indomethacin administered icv in the normal rats was 17 times higher than the brain level of non-metabolized indomethacin administered systemically. The icv effective dose of aminopyrine was 4-4.5 times higher than the level of the brain concentration of non-metabolized drug in both types of rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146738     DOI: 10.1254/jjp.35.95

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  14 in total

1.  Central, naloxone-reversible antinociception by diclofenac in the rat.

Authors:  R Björkman; J Hedner; T Hedner; M Henning
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

Review 2.  Do the pharmacodynamics of the nonsteroidal anti-inflammatory drugs suggest a role in the management of postoperative pain?

Authors:  L E Mather
Journal:  Drugs       Date:  1992       Impact factor: 9.546

3.  Effects of systemic non-steroidal anti-inflammatory drugs on nociception during tail ischaemia and on reperfusion hyperalgesia in rats.

Authors:  L Gelgor; N Butkow; D Mitchell
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

4.  [Not Available].

Authors:  I Jurna
Journal:  Schmerz       Date:  1992-03       Impact factor: 1.107

5.  A recursive-partitioning model for blood-brain barrier permeation.

Authors:  S R Mente; F Lombardo
Journal:  J Comput Aided Mol Des       Date:  2005-12-06       Impact factor: 3.686

6.  Piroxicam-induced analgesia: evidence for a central component which is not opioid mediated.

Authors:  A Fabbri; G Cruccu; P Sperti; M Ridolfi; T Ciampani; M G Leardi; S Ferracuti; V Bonifacio
Journal:  Experientia       Date:  1992-12-01

Review 7.  Differential analgesic effects of aspirin-like drugs.

Authors:  K Brune; S Menzel-Soglowek; H U Zeilhofer
Journal:  Drugs       Date:  1992       Impact factor: 9.546

8.  Morphine-sparing effect of diclofenac in cancer pain.

Authors:  R Björkman; A Ullman; J Hedner
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Lack of activity of ketorolac in hot-plate test and serotonin binding capacity of brain membranes in rats.

Authors:  G Vitale; M Sandrini; L A Pini
Journal:  Agents Actions       Date:  1994-05

Review 10.  The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects.

Authors:  K McCormack
Journal:  Drugs       Date:  1994       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.